[Footnote 1] 641.3007 Human immunodeficiency
virus infection and acquired immune deficiency syndrome for contract
purposes. ---
(1) PURPOSE. The purpose of this section is to prohibit
unfair practices in a health maintenance organization contract with respect to
exposure to the human immunodeficiency virus infection and related matters,
and thereby reduce the possibility that a health maintenance organization
subscriber or applicant may suffer unfair discrimination when subscribing to
or applying for the contractual services of a health maintenance
organization.
(2) SCOPE. This section applies to all health maintenance
contracts which are issued in this state or which are issued outside this
state but cover residents of this state. This section shall not prohibit a
health maintenance organization from contesting a contract or claim to the
extent allowed by law.
(3) DEFINITIONS. As used in this section:
(a) "AIDS" means acquired immune deficiency syndrome.
(b) "ARC" means AIDS-related complex.
(c) "HIV" means human immunodeficiency virus identified as the
causative agent of AIDS.
(4) UTILIZATION OF MEDICAL TESTS.
(a) With respect to the issuance of or the underwriting of a health
maintenance organization contract regarding exposure to the HIV infection and
sickness or medical conditions derived from such infection, a health
maintenance organization shall only utilize medical tests which are reliable
predictors of risk. A test which is recommended by the Centers for Disease
Control or by the federal Food and Drug Administration is deemed to be
reliable for the purposes of this section. A test which is rejected or not
recommended by the Centers for Disease Control or the federal Food and Drug
Administration is a test which is deemed to be not reliable for the purposes
of this section. If a specific Centers for Disease Control or federal Food
and Drug Administration recommended test indicates the existence or potential
existence of exposure by the HIV infection or a sickness or medical condition
related to the HIV infection, before relying on a single test result to deny
or limit coverage or to rate the coverage, the health maintenance organization
shall follow the applicable Centers for Disease Control or federal Food and
Drug Administration recommended test protocol and shall utilize any applicable
Centers for Disease Control or federal Food and Drug Administration
recommended followup tests or series of tests to confirm the indication.
(b) Prior to testing, the health maintenance organization must
disclose its intent to test the person for the HIV infection or for a specific
sickness or medical condition derived therefrom and must obtain the person's
written informed consent to administer the test. Written informed consent
shall include a fair explanation of the test, including its purpose, potential
uses, and limitations, and the meaning of its results and the right to
confidential treatment of information. Use of a form approved by the
department shall raise a conclusive presumption of informed consent.
(c) An applicant shall be notified of a positive test result by a
physician designated by the applicant or, in the absence of such designation,
by the Department of Health and Rehabilitative Services. Such notification
must include:
1. Face-to-face posttest counseling on the meaning of the test
results; the possible need for additional testing; and the need to eliminate
behavior which might spread the disease to others;
2. The availability in the geographic area of any appropriate health
care services, including mental health care, and appropriate social and
support services;
3. The benefits of locating and counseling any individual by whom
the infected individual may have been exposed to human immunodeficiency virus
and any individual whom the infected individual may have exposed to the virus;
and
4. The availability, if any, of the services of public health
authorities with respect to locating and counseling any individual described
in subparagraph 3.
(d) A medical test for exposure to the HIV infection or for a
sickness or medical condition derived from such infection shall only be
required of or given to a person if the test is required or given to all
subscribers or applicants or if the decision to require the test is based on
the person's medical history. Sexual orientation shall not be used in the
underwriting process or in the determination of which subscribers or
applicants for enrollment shall be tested for exposure to the HIV infection.
Neither the marital status, the living arrangements, the occupation, the
gender, the beneficiary designation, nor the zip code or other territorial
classification of an applicant shall be used to establish the applicant's
sexual orientation.
(e) A health maintenance organization may inquire whether a person
has been tested positive for exposure to the HIV infection or been diagnosed
as having AIDS or ARC caused by the HIV infection or other sickness or medical
condition derived from such infection. A health maintenance organization shall
not inquire whether a person has been tested for or has received a negative
result from a specific test for exposure to the HIV infection or for a
sickness or medical condition derived from such infection.
(f) A health maintenance organization shall maintain strict
confidentiality regarding medical test results with respect to the HIV
infection or a specific sickness or medical condition derived from such
infection. Information regarding specific test results shall not be disclosed
outside the health maintenance organization, its employees, its marketing
representatives, or its insurance affiliates, except to the person tested and
to persons designated in writing by the person tested. Specific test results
shall not be furnished to an insurance industry or health maintenance
organization data bank if a review of the information would identify the
individual and the specific test results.
(g) No laboratory may be used by an insurer or insurance support
organization for the processing of HIV-related tests unless it is certified by
the United States Department of Health and Human Services under the Clinical
Laboratories Improvement Act of 1967, permitting testing of specimens obtained
in interstate commerce, and subjects itself to ongoing proficiency testing by
the College of American Pathologists, the American Association of Bio
Analysts, or an equivalent program approved by the Centers for Disease Control
of the United States Department of Health and Human Services.
(5) RESTRICTIONS ON CONTRACT EXCLUSIONS AND LIMITATIONS.
(a) A health maintenance organization contract shall not exclude
coverage of a member of a subscriber group because of a positive test result
for exposure to the HIV infection or a specific sickness or medical condition
derived from such infection, either as a condition for or subsequent to the
issuance of the contract, provided that this prohibition shall not apply to
persons applying for enrollment where individual underwriting is otherwise
allowed by law.
(b) No health maintenance organization contract shall exclude or
limit coverage for exposure to the HIV infection or a specific sickness or
medical condition derived from such infection, except as provided in a
preexisting condition clause.
History: ss. 51, 54, ch. 88-380; s. 188, ch. 91-108; s. 4, ch. 91-429; s. 45, ch.
95-211.
[Footnote 1] Note.
A. Expired October 1, 1991, pursuant to s. 54, ch. 88-380, and
scheduled for review by the Legislature prior to that date.
B. Section 187, ch. 91-108, provides, in part, that
"notwithstanding the Regulatory Sunset Act or any other provision
of law which provides for review and repeal in accordance with s. 11.61,
Florida Statutes, and except as otherwise specifically provided herein,
ch. 641 shall not stand repealed on October 1, 1991, and shall
continue in full force and effect as
amended...."